The review gives data on the clinical manifestations, complications, and epidemiological characteristics of herpes zoster.


如何引用文章

全文:

详细

It discusses prospects for and foreign experience with vaccination against chickenpox and exacerbations of herpes zoster. The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines

全文:

Клинико-эпидемиологическая характеристика и вакцинопрофилактика опоясывающего лишая (herpes zoster). - Аннотация. В обзоре представлены данные о клинических проявлениях, осложнениях, эпидемиологических характеристиках опоясывающего лишая. Обсуждаются перспективы и зарубежный опыт вакцинопрофилактики ветряной оспы и обострений herpes zoster.
×

参考

  1. Покровский В.И., Пак С.Г., Брико Н.И., Данилкин Б.К. Инфекционные болезни и эпидемиология. М: ГЭОТАР-Медиа 2007; 832.
  2. Breuer J., Whitley R. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster. Herpes 2007; 14 (Suppl. 2): 25-29.
  3. Черкасский Б.Л. Частная эпидемиология. Руководство для врачей. Т. 1. М: ИНТЕРСЭН 2002; 388.
  4. Atkinson W., Hamborsky J., McIntyre L., Wolfe S. (eds). Epidemiology and prevention of vaccine-preventable diseases, 10th ed. Washington DC: Public Health Foundation 2007: 175-196.
  5. Yoshikava T., Ihira M., Suzuki K. et al. Rapid contamination of varicella - zoster virus DNA from a patient with herpes zoster. J Med Virol 2001; 63 (l): 64-66.
  6. Johnson R.W., Rice A.S. Pain following herpes zoster: the influence of changing population characteristics and medical developments. Pain 2007; 128 (1-2): 3-5.
  7. Kennedy P.G., Grinfeld E., Gow J.W. Latent Varicella Zoster virus in human dorsal root ganglia. Virology 1999; 258 (2): 451-454.
  8. Zerboni L., Ku Chai-Chi, Jones C.D. et al. Varicella zoster virus infection of human dorsal root ganglia in vivo. Proc Nat Acad Sci USA 2005; 102 (18): 6490-6495.
  9. Loeser J.D. Herpes zoster and postherpetic neuralgia. Pain 1986; 25 (2): 149-164.
  10. Portenoy R.K., Duma C., Foley K.M. Acute herpetic and postherpetic neuralgia: clinical review аnd current management. Ann Neurol 1986; 20 (6): 651-664.
  11. Peter C., Watson N., Gershon A.A. (ed.) Herpes zoster and postherpetic neuralgia. Amsterdam etc.: Elsevier 2001: 280.
  12. Исаков В.А., Архипова Е.И., Исаков Д.В. Герпесвирусные инфекции человека: руководство для врачей. СПб: Спецлит 2006; 301.
  13. Yawn B., Saddier P., Wollan P. et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82: 1341-1349.
  14. World Health Organization: The WHO position paper on varicella vaccines. Wkly Epidemiol Rec 1998; 73: 241-248.
  15. Strommen G.L., Pucino F., Tight R.R. et al. Human infection with herpes zoster: etiology, pathophysiology, diagnosis, clinical course, and treatment. Pharmacotherapy 1988; 8 (1): 652-684.
  16. Scott F.T., Johnson R.W., Leedham-Green M. et al. The burden of herpes zoster: a prospective population based study. Vaccine 2006; 24: 1308-1314.
  17. National Advisory Committee on Immunization (NACI): Update to statement on varicella vaccine. An advisory committee statement (ACS). Can Commun Dis Rep 2002; 28: 1-7.
  18. Schmader K., Gnann J.W., Watson P. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis 2008; 197 (Suppl. 2): 207-215.
  19. Chidiac C., Bruxelle J., Daures J.P. et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001; 33: 62-69.
  20. Chapman R.S., Cross K., Fleming D.M. The incidence of shingles and its implications for vaccination policy. Vaccine 2003; 21: 2541-2547.
  21. Lancaster T., Silagy C., Gray S. Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. Br J Gen Pract 1995; 45: 39-45.
  22. Choo P., Galil K., Donahue J. et al. Risk factors for postherpetic neuralgia. Arch Intern Med 1997; 157: 1217-1224.
  23. Davies L., Cossins L., Bowsher D., Drummond M. The cost of treatment for postherpetic neuralgia in the UK. Phamacoeconomics 1994; 6: 142-148.
  24. Dworkin R.H., Portenoy R.K. Pain and its persistence in herpes zoster. Pain 1996; 67: 241-251.
  25. Волкова Л.И. Современные аспекты лечения и профилактики постгерпетической невралгии. Фармацевт вестн 2006; 16: 421.
  26. Иванова М.А. Эпидемиологическая, клинико-иммунологическая характеристика опоясывающего герпеса в Башкортостане: Автреф. дис. ... канд. мед. наук. Уфа 2007; 23.
  27. Attal N., Gruccu G., Haanpaa M. at al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153-1169.
  28. Arvin A. Aging, immunity and the varicella zoster virus. N Engl J Med 2005; 352: 2266-2267.
  29. Kihara T., Shimohama S. Occipital neuralgia evoked by facial herpes zoster infection. Headache 2006; 46 (10): 1590-1591.
  30. Nishioka K., Fujishima K., Koba-yashi H. et al. An extremely unusual presentation of varicella zoster viral infection of cranial nerves mimicking Garcin syndrome. Clin Neurol Neurosurg 2006; 108 (8): 772-774.
  31. Степанченко A.B. Постгерпетическая тригеминальная невралгия. Нейроинфекции: матер. I Нац. конф. с междунар. уч. М 2007: 139-140.
  32. Cohrs R.J., Laguardia J.J., Gilden D. Distribution of latent herpes simplex virus type 1 and, varicella zoster virus DNA in human trigeminal ganglia. Virus Genes 2005; 31 (2): 223-227.
  33. Уманский К.Г., Смирнов Ю.К., Шишов A.C. Патогенетический анализ синдрома Рамзая Хунта. Журн невропатол и психиатр 1979; 8: 1011-1016.
  34. Шишов A.C., Вирыч И.Е., Багров Ф.И., Латышева И.Т. Синдром Гийена-Барре у больных опоясывающим лишаем. Журн неврол и психиатр 1996; 2: 26-29.
  35. Mancuso R., Delbue S., Borghi E. et al. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol 2007; 79 (2): 192-199.
  36. Mancuso M., Virgili M.P., Pizzanelli C. et al. Abdominal pseudohernia caused by herpes zoster truncal D12 radiculoneuropathy. Arch Neurol 2006; 63 (9): 1327.
  37. Estraneo A., Saltalamacchia A.M., Loreto V. Spinal myoclonus following herpes zoster radiculitis. Neurology 2007; 68 (5): 149.
  38. Eyigor S., Durmaz B., Karapolat H. Monoparesis with complex regional pain syndrome-like symptoms due to brachial plexopathy caused by the varicella zoster virus: a case report. Arch Phys Med Rehabil 2006; 87 (12): 1653-1655.
  39. Mathis S., Gil R., Neau J.P. Neurological complications of Herpes zoster. Rev Neurol (Paris) 2006; 162 (8-9): 879-887.
  40. Thomas S.L., Hall A.J. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004; 4: 26-33.
  41. Gelb L.D. Varicella zoster virus infection. Current Opinion in Infectious Diseases 1989; 2: 256-261.
  42. Opstelten W., Van Essen G.A., Schellevis F. et al. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol 2006; 16(9): 692-695.
  43. Grann J., Whitley R. Herpes Zoster. N Engl J Med 2002; 347: 340-346.
  44. Insinga R.P., Itzler R.F., Pellissier J.M. et al. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005; 20: 748-53.
  45. Leung A.K., Robson W.L., Leong A.G. Herpes zoster in childhood. J. Pediatr. Health Care 2006; 20 (5): 300-303.
  46. Sauerbrei A., Wutzler P. Neonatal varicella. J Perinatol 2001; 21: 545-549.
  47. Sauerbrei A., Wutzler P. The congenital varicella syndrome. J Perinatol 2000; 20: 548-554.
  48. Sauerbrei A., Wutzler P. Varicella-zoster virus infections during pregnancy: epidemiology, clinical symptoms, diagnosis, prevention and therapy. Curr Pediat Rev 2005; 1: 205-216.
  49. West S.L., Newton R.W., Bail-dam E.M. et al. Recurrent hemiplegia associated with cerebral vasculopathy following third trimester maternal herpes zoster infection. Dev Med Child Neurol 2006; 48 (12): 991-993.
  50. Селькова Е.П. Эпидемиология ветряной оспы. Вакцинация 2009; 1: 5-7.
  51. Лобзин Ю.В. Руководство по инфекционным болезням. СПб: Фолиант 2000; 932.
  52. Серебряков М.Ю., Серебряков Д.Ю., Тищенко М.С. Лечение Herpes Zoster у больного с ВИЧ инфекцией. Венеролог 2005; 5: 77-78.
  53. Patel A.K., Patel K.K., Shah S.D., Desai J. Immune reconstitution syndrome presenting with cerebral varicella zoster vasculitis in HIV-1-infected patient: a case report. J. Int. Assoc. Physicians. AIDS Care. (Chic 111) 2006; 5 (4): 157-160.
  54. Grote V., von Kries R., Rosenfeld E. Immunocompetent children account for the majority of complications in childhood herpes zoster. J Infect Dis 2007; 196: 1455-1458.
  55. Jumaan A.O., Yu O., Jackson L.A. et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 2005; 191: 2002-2007.
  56. Tseng H.F., Smith N., Harpaz R. et al. Herpes zoster vaccine in older adults and the risk of subsequent zoster disease. JAMA 2011; 305: 160-166.
  57. Кимберлин Д.У., Уитли Р.Д. Профилактика опоясывающего лишая с помощью вакцины. РМЖ 2008; 16 (9): 5919.
  58. Moon M.A. Herpes Zoster Vaccine Effective in Real Practice. Fam Prac News. 2011 // [http://www.cdc.gov/shingles/downloads/fam-prac-news-zoster-vac.pdf].
  59. Barclay P., Murata P., Martin B.N. Guidelines Issued on Prevention of Herpes Zoster. MMWR Rep 2008; 57: 1-30.
  60. Coplan P.M., Schmader K., Nikas A. et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory. J Pain 2004; 5: 344-356.
  61. Harpaz R., Ortega-Sanchez I.R., Seward J.F. Prevention of Herpes Zoster. Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2008; 57: 1-30.
  62. ACIP. Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices June 22, 2007 / 56(RR04): 1-40.
  63. Guess H.A., Broughton D.D., Melton L.J. et al. Population-based studies of varicella complications. Pediatrics 1986; 78 (Suppl. 1): 723-727.
  64. Hammerschlag M.R., Gershon A., Steinberg S. et al. Herpes zoster in an adult recipient of live attenuated varicella vaccine. J Infect Dis 1989; 160: 535-537.
  65. Reynolds M.A., Chaves S.S., Harpaz R. et al. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis 2008; 197 (Suppl 2): 224-227.
  66. Wagenpfeil S., Neiss A., Wutzler P. Effect of varicella vaccination on herpes zoster incidence. Clin Microbiol Infect 2004; 10: 954-960.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Consilium Medicum, 2013

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


##common.cookie##